|
LOC284441 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.246600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.508000E-01 |
| Normal-vs-Stage2 |
7.120600E-01 |
| Normal-vs-Stage3 |
1.925950E-01 |
| Normal-vs-Stage4 |
6.540500E-02 |
| Stage1-vs-Stage2 |
5.280200E-01 |
| Stage1-vs-Stage3 |
7.517500E-02 |
| Stage1-vs-Stage4 |
1.733520E-02 |
| Stage2-vs-Stage3 |
5.443800E-01 |
| Stage2-vs-Stage4 |
2.660800E-01 |
| Stage3-vs-Stage4 |
5.106000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.190400E-01 |
| Normal-vs-AfricanAmerican |
7.632200E-02 |
| Normal-vs-Asian |
9.846400E-01 |
| Caucasian-vs-AfricanAmerican |
7.677800E-02 |
| Caucasian-vs-Asian |
9.117000E-01 |
| AfricanAmerican-vs-Asian |
4.778800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.094600E-01 |
| Normal-vs-Female |
5.883800E-01 |
| Male-vs-Female |
8.110000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.255400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.378600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.273800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.476200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.898800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.723200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.414800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.602600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.423800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.102800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.532000E-01 |
| Normal-vs-Grade 2 |
9.115200E-01 |
| Normal-vs-Grade 3 |
3.031800E-01 |
| Normal-vs-Grade 4 |
1.934240E-01 |
| Grade 1-vs-Grade 2 |
6.110200E-01 |
| Grade 1-vs-Grade 3 |
1.914620E-01 |
| Grade 1-vs-Grade 4 |
1.229420E-01 |
| Grade 2-vs-Grade 3 |
2.100600E-01 |
| Grade 2-vs-Grade 4 |
1.522180E-01 |
| Grade 3-vs-Grade 4 |
5.390800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.781800E-01 |
| Normal-vs-ccB subtype |
3.921000E-01 |
| ccA subtype-vs-ccB subtype |
4.644000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.479000E-01 |
| Normal-vs-N1 |
8.326400E-01 |
| N0-vs-N1 |
7.974400E-01 |
|
|
